Artiva Biotherapeutics (ARTV) Change in Acquisitions & Divestments (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $22.0 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 24.14% year-over-year to $22.0 million in Q1 2026; TTM through Mar 2026 was $103.9 million, a 49.78% increase from a year earlier, with the FY2025 full-year figure at $110.9 million, up 96.76% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $22.0 million, down from $24.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for ARTV reached as high as $29.6 million in Q3 2025 and fell as low as $12.0 million in Q3 2023.
• Historically, Change in Acquisitions & Divestments has averaged $19.5 million across 4 years, with a median of $16.0 million in 2024.
• Across the five-year window, Change in Acquisitions & Divestments soared 138.9% in 2025 and fell 24.14% in 2026, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $12.8 million in 2023, then rose by 8.98% to $14.0 million in 2024, then soared by 72.04% to $24.0 million in 2025, then decreased by 8.33% to $22.0 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $22.0 million in Q1 2026, $24.0 million in Q4 2025, and $29.6 million in Q3 2025.